Columbia University has bowed to President Trump's demands and canceled $400 million in funding, impacting ongoing research projects on cancer and COVID-19. The university's decision to accede to the demands has outraged faculty members, who argue that academic freedom has been sacrificed. Scientific and medical researchers are appalled that their work has been drawn into the political debate. The funding cuts have forced researchers to make difficult decisions and prioritize which treatments and patients they can focus on.